Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees
14/05/2026 09:42
May 14 (Reuters) - Senores Pharmaceuticals Ltd SENO.NS: MARCH-QUARTER CONSOL NET PROFIT 316.1 MILLION RUPEES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.75 BILLION RUPEES Source text: [ID:] Further company coverage: SENO.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees